Physician profile

Noah Kirschner

Fair Lawn, NJ

$25,171.60

in general payments reported to CMS, 2019-2025

6 companies · $25K in 2025

The $25K reported for 2025 was more than what 99% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$20,000.00
Travel and Lodging$2,878.15
Food and Beverage$2,293.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $21,977.11 2024-2025
Stryker Corporation $1,718.05 2025 Iconix, Alphavent, Pangea
Suvon Surgical LLC $584.19 2025
Seapearl East, INC $482.90 2025
Sanara Medtech INC. $371.86 2025 Celleraterx
Gotham Surgical Solutions & Devices, INC. $37.49 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Noah Kirschner

$25,171.60

in general payments reported 2019-2025

Years
2024-2025
Top company
Arthrex, INC.
Context
The $25K reported for 2025 was more than what 99% of providers received nationally.

https://glasscript.com/doctor/11701822/noah-kirschner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.